Pharmacovigilance study of BCR-ABL1 tyrosine kinase inhibitors: a safety analysis of the FDA adverse event reporting system
Article in BMC Pharmacology and Toxicology (February 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in BMC Pharmacology and Toxicology (February 2024)
Article in The Egyptian Heart Journal (February 2024)
Article in Pharmacological Research (January 2024)